SEP 03, 2021 7:15 PM PDT

Is a Venom-Like Molecule Involved in COVID-19 Mortality?

WRITTEN BY: Carmen Leitch

Scientists have sought to learn more about why some people get severe COVID-19 while others have only mild cases. We now know that there are multiple risk factors that may cause more serious cases, but researchers are still investigating the biological mechanisms that lead to death in COVID-19 patients. Recent work has suggested that many COVID-19 deaths are due to the failure of multiple organs and septic shock, when the body is overwhelmed by the immune response to massive infection. Though the original disease is due to infection with the SARS-CoV-2 virus, many COVID-19 patients also get bacterial infections in their lungs.

Colorized scanning electron micrograph of an apoptotic cell (red) heavily infected with SARS-CoV-2 virus particles (green), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland./ Credit: NIAID

Scientists have now identified an enzyme that is normally present at low levels in the body, but was found to be very high in some COVID-19 patients. The findings, reported in the Journal of Clinical Investigation, suggested that the enzyme, called secreted phospholipase A2 group IIA, or sPLA2-IIA, could be the most critical factor in whether or not patients die from COVID-19. The sPLA2-IIA enzyme plays an important defensive role in the body against bacterial pathogens; it can destroy the cell membranes of microbes. The enzyme also has similarities to an enzyme found in rattlesnake venom.

When it circulates at high levels in the human body, activated sPLA2-IIA can attack the membranes that surround and protect vital organs, noted senior study author Floyd (Ski) Chilton, Director of the University of Arizona (UArizona) Precision Nutrition and Wellness Initiative.

The body has to strike a balance between using processes that will destroy an infection, while also leaving the host unharmed. "In other words, this enzyme is trying to kill the virus, but at a certain point it is released in such high amounts that things head in a really bad direction, destroying the patient's cell membranes and thereby contributing to multiple organ failure and death," explained Chilton, who is featured in the video below discussing this work.

The researchers analyzed thousands of different aspects of patient health, including commonly known factors like age or preexisting conditions, as well as biochemical molecules and lipid metabolite levels. Samples were obtained from two different groups of patients, one with 127 inpatients at Stony Brook Hospital, and another with 154 people attending either Stony Brook or Banner University Medical Center in Tucson

The researchers acknowledged that the sample groups are small, but the study was conducted rapidly in the clinical setting during a pandemic, and was not planned out over years like many clinical studies. The work still enabled the researchers to find patterns of metabolites in those who died of COVID-19. As they expected, they saw energy dysfunction in the cells of these patients. But they were surprised by high sPLA2-IIA enzyme levels," said lead study author Justin Snider, an assistant research professor in the UArizona Department of Nutrition.

Computational tools revealed that in healthy people, sPLA2-IIA enzyme levels are about half a nanogram per milliliter. But the sPLA2-IIA level was around ten nanograms per milliliter or more in 63 percent of COVID-19 patients who had died of the illness.

"Many patients who died from COVID-19 had some of the highest levels of this enzyme that have ever been reported," said Chilton. The enzyme is well-studied, he noted.

It has a reputation as a "shredder" because it can often be found in severe cases of inflammation, like cardiac shock or bacterial sepsis, added study co-author Charles McCall of Wake Forest University.

Since sPLA2-IIA inhibitors are available, they may be a way to reduce death in COVID-19 patients.

Now, the researchers are want to learn whether sPLA2-IIA is involved in long COVID cases.

Interestingly, researchers are also investigating whether a molecule found in jararacussu pit viper venom may be useful as a COVID-19 therapeutic, as described in the video above. The molecule stopped COVID-19 from multiplying in infected cells.

Sources: University of Arizona, Journal of Clinical Investigation

 

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 04, 2021
Cell & Molecular Biology
Consuming Too Much Sugar Could Disrupt the Cell's Powerhouses
AUG 04, 2021
Consuming Too Much Sugar Could Disrupt the Cell's Powerhouses
Both processed and prepared foods often contain high levels of sugar. It's thought that the average American eats almost ...
AUG 23, 2021
Microbiology
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
AUG 23, 2021
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
Several viruses are known to cause chronic infections, one is hepatitis C virus (HCV). Researchers studying these infect ...
AUG 25, 2021
Cell & Molecular Biology
An Atomic-Level Look at Infectious Proteins
AUG 25, 2021
An Atomic-Level Look at Infectious Proteins
Scientists have used a tool called cryo-electron microscopy to get an unprecedented and detailed look at infectious, mis ...
SEP 15, 2021
Cell & Molecular Biology
The Molecular 'Anchors' That Hold Cells in Place
SEP 15, 2021
The Molecular 'Anchors' That Hold Cells in Place
Cells in the body are held in place with a kind of molecular anchor, called focal adhesions, where cells are linked to c ...
SEP 18, 2021
Genetics & Genomics
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
SEP 18, 2021
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
The DNA in our cells can accumulate damage over may years. Environmental influences like UV light or cigarette smoke may ...
SEP 24, 2021
Cell & Molecular Biology
A Human Embryo Model is Made From Stem Cells
SEP 24, 2021
A Human Embryo Model is Made From Stem Cells
This photo by Sozen & Jorgensen et al., Nature Communications, shows an embryo-like structure made from human stem cells ...
Loading Comments...